Outcomes of COVID-19 Among Hospitalized Patients With Non-dialysis CKD.
Front Med (Lausanne)
; 7: 615312, 2020.
Article
en En
| MEDLINE
| ID: mdl-33344488
ABSTRACT
Background:
Coronavirus disease 2019 (COVID-19), caused by Severe Acute Respiratory Syndrome-Corona Virus 2 has generated significant impact on global health worldwide. COVID-19 can cause pneumonia and organ injury. Chronic kidney disease (CKD) has been associated with increased mortality in previous epidemics, but there is a paucity of data regarding actual risks for non-dialysis CKD patients with COVID-19.Methods:
Multicenter, observational cohort study including 136 non-dialysis CKD patients and 136 age- and sex-matched controls that required hospitalization due to COVID-19. Patients with end-stage renal disease, a kidney transplant or without registered baseline glomerular filtration rate prior to COVID-19 infection were excluded. CKD and acute kidney injury (AKI) were defined according to KDIGO criteria.Results:
CKD patients had higher white blood cell count and D-dimer and lower lymphocyte percentage. No differences were found regarding symptoms on admission. CKD was associated with higher rate of AKI (61 vs. 24.3%) and mortality (40.4 vs. 24.3%). Patients with AKI had the highest hazard for death (AKI/non-CKD HR7.04, 95% CI2.87-17.29; AKI/CKD HR5.25, 95% CI 2.29-12.02), followed by CKD subjects without AKI (HR3.39, 95% CI1.36-8.46). CKD status did not condition ICU admission or length of in-hospital stay.Conclusions:
CKD patients that require hospitalization due to COVID-19 are exposed to higher risk of death and AKI.
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Contexto en salud:
2_ODS3
/
4_TD
/
6_ODS3_enfermedades_notrasmisibles
Problema de salud:
2_cobertura_universal
/
4_covid_19
/
6_chronic_kidney_disease
Tipo de estudio:
Clinical_trials
/
Observational_studies
/
Risk_factors_studies
Idioma:
En
Revista:
Front Med (Lausanne)
Año:
2020
Tipo del documento:
Article
País de afiliación:
España